Literature DB >> 9538478

Assessment of disease activity in systemic vasculitis.

W Y Tse1, P Cockwell, C O Savage.   

Abstract

The systemic vasculitides are a group of inflammatory disorders characterised by relapses and remission. Before the introduction of immunosuppressive drugs, mortality was unacceptably high. Immunosuppressive therapy has had a therapeutic impact, but at the cost of increased risk of infection and other adverse effects. Differentiating infection from active disease can be difficult, and the inappropriate prescription of immunosuppressive drugs can be fatal. Hence disease indices which can aid physicians to identify the active phase of disease and enable early treatment, will be valuable in the management of this group of disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9538478      PMCID: PMC2360776          DOI: 10.1136/pgmj.74.867.1

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  40 in total

1.  Association between active Wegener's granulomatosis and anticytoplasmic antibodies.

Authors:  J W Tervaert; F J van der Woude; A S Fauci; J L Ambrus; J Velosa; W F Keane; S Meijer; M van der Giessen; G K van der Hem; T H The
Journal:  Arch Intern Med       Date:  1989-11

2.  Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis.

Authors:  G Gaskin; C O Savage; J J Ryan; S Jones; A J Rees; C M Lockwood; C D Pusey
Journal:  Nephrol Dial Transplant       Date:  1991       Impact factor: 5.992

Review 3.  Criteria for disease activity in Wegener's granulomatosis: a requirement for longitudinal clinical studies.

Authors:  C G Kallenberg; J W Tervaert; C A Stegeman
Journal:  APMIS Suppl       Date:  1990

4.  Enhanced expression of the tumour necrosis factor/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitis.

Authors:  Y Deguchi; N Shibata; S Kishimoto
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

5.  Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis: a longitudinal study.

Authors:  E Pettersson; Z Heigl
Journal:  Clin Nephrol       Date:  1992-05       Impact factor: 0.975

6.  Serum soluble interleukin 2 receptor in systemic lupus erythematosus: effects of disease activity and infection.

Authors:  K L Wong; R P Wong
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

7.  The role of antineutrophil cytoplasm antibodies, anticardiolipin antibodies, von Willebrand factor antigen, and fibronectin for the diagnosis of systemic vasculitis.

Authors:  L Bleil; B Manger; T H Winkler; M Herrman; G R Burmester; F E Krapf; J R Kalden
Journal:  J Rheumatol       Date:  1991-08       Impact factor: 4.666

Review 8.  Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders.

Authors:  C G Kallenberg; A H Mulder; J W Tervaert
Journal:  Am J Med       Date:  1992-12       Impact factor: 4.965

9.  Wegener granulomatosis: an analysis of 158 patients.

Authors:  G S Hoffman; G S Kerr; R Y Leavitt; C W Hallahan; R S Lebovics; W D Travis; M Rottem; A S Fauci
Journal:  Ann Intern Med       Date:  1992-03-15       Impact factor: 25.391

10.  Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity.

Authors:  W H Schmitt; C Heesen; E Csernok; A Rautmann; W L Gross
Journal:  Arthritis Rheum       Date:  1992-09
View more
  3 in total

Review 1.  Giant cell arteritis: Current treatment and management.

Authors:  Cristina Ponte; Ana Filipa Rodrigues; Lorraine O'Neill; Raashid Ahmed Luqmani
Journal:  World J Clin Cases       Date:  2015-06-16       Impact factor: 1.337

2.  Clinical [corrected] and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre.

Authors:  M Chen; F Yu; Y Zhang; M H Zhao
Journal:  Postgrad Med J       Date:  2005-11       Impact factor: 2.401

3.  Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases.

Authors:  Mai Kawazoe; Kaichi Kaneko; Kotaro Shikano; Natsuko Kusunoki; Toshihiro Nanki; Shinichi Kawai
Journal:  Clin Rheumatol       Date:  2017-05-27       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.